ArticleCancer medicine2020
Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models.
Andrew T Stefka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ArticleCancer medicine2020
Andrew T Stefka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.